Skip to content

Net Income at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$727.2M-10.1%
Opko Health logo
Opko HealthOPK
-$54.85M+18.9%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$73.29M+4.9%
ALN
Alnylam PharmaceuticalsALNY
$205.99M+1,229%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-$96.23M+15.8%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-$58.16M-1.2%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+31.9%
Enterprise value$1.07B+26.9%
P/S13.5×-10.1×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's net income?
MeiraGTx Holdings plc (MGTX) reported net income of -$46.31M in Q1 2026.
How has MeiraGTx Holdings plc's net income changed year-over-year?
MeiraGTx Holdings plc's net income decreased by 15.8% year-over-year, from -$39.98M to -$46.31M.
What is the long-term trend for MeiraGTx Holdings plc's net income?
Over 2 years (2021 to 2024), MeiraGTx Holdings plc's net income has grown at a 36.3% compound annual growth rate (CAGR), from -$79.56M to -$147.79M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.